Today we launched BioLargo’s updated website! Replacing the
company’s original (and sorely outdated) website, the new page uses modern web
design tools and assets, making it a huge aesthetic and functional upgrade. You
can find the website at the same URL – www.biolargo.com. We encourage our
followers and shareholders to explore the new site and see the improvements for
themselves.
We are very excited about the new site, as it represents a
big improvement to the company’s digital presence. BioLargo is a fast-moving
and dynamic company with many high growth potential assets and business units,
and its online presence must be of a standard befitting our exciting and
important portfolio. We think this new website represents a significant step
toward that goal.
You can comment on our new website on Twitter at @BioLargo
– we’d love to hear from you!
What is a BioLargo
Spotlight?
It’s an exciting time
at BioLargo. We’re moving fast, and it can be difficult to keep our
stockholders and the investing public informed of our progress. In light of
this, we will be posting a series of short articles titled “BioLargo
Spotlight”, highlighting certain business activities and other important
information in between our required SEC filings. Of course, these do not
replace our public filings, which contain more complete information than can be
delivered in this forum, and thus we urge you to carefully read and rely on
those filings for definitive information, and to review our risk factors and
caution regarding forward-looking statements. We are optimistic about our
business as we work hard to continue to grow and ultimately generate profits
for our stockholders.
Legal Disclaimer
Our attorneys remind
us that while we believe these developments are important and that these small
victories could add up and lead to big victories, at this stage they do not
rise to the level of an official material disclosure. As the size and magnitude
of these developments become material, we will naturally report that
information in an 8-K and our regular SEC filings.
No comments:
Post a Comment